MetLife Investment Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$215K Buy
26,240
+2,694
+11% +$22.1K ﹤0.01% 2150
2025
Q1
$168K Sell
23,546
-3,643
-13% -$26K ﹤0.01% 2287
2024
Q4
$210K Hold
27,189
﹤0.01% 2282
2024
Q3
$285K Hold
27,189
﹤0.01% 2094
2024
Q2
$318K Buy
27,189
+6,740
+33% +$78.9K ﹤0.01% 1969
2024
Q1
$431K Sell
20,449
-1,878
-8% -$39.6K ﹤0.01% 1758
2023
Q4
$401K Hold
22,327
﹤0.01% 1821
2023
Q3
$368K Hold
22,327
﹤0.01% 1815
2023
Q2
$446K Hold
22,327
﹤0.01% 1770
2023
Q1
$422K Hold
22,327
﹤0.01% 1748
2022
Q4
$506K Sell
22,327
-935
-4% -$21.2K ﹤0.01% 1638
2022
Q3
$615K Buy
23,262
+2,096
+10% +$55.4K 0.01% 1483
2022
Q2
$523K Sell
21,166
-2,326
-10% -$57.5K ﹤0.01% 1628
2022
Q1
$780K Buy
23,492
+8,295
+55% +$275K 0.01% 1486
2021
Q4
$497K Hold
15,197
﹤0.01% 1508
2021
Q3
$637K Hold
15,197
0.01% 1390
2021
Q2
$590K Hold
15,197
0.01% 1474
2021
Q1
$518K Hold
15,197
﹤0.01% 1503
2020
Q4
$689K Hold
15,197
0.01% 1313
2020
Q3
$418K Hold
15,197
﹤0.01% 1457
2020
Q2
$560K Hold
15,197
0.01% 1318
2020
Q1
$492K Hold
15,197
0.01% 1224
2019
Q4
$623K Hold
15,197
0.01% 1332
2019
Q3
$541K Hold
15,197
0.01% 1377
2019
Q2
$781K Buy
15,197
+1,104
+8% +$56.7K 0.01% 1234
2019
Q1
$808K Hold
14,093
0.01% 1181
2018
Q4
$591K Hold
14,093
0.01% 1263
2018
Q3
$1.06M Buy
14,093
+876
+7% +$66.1K 0.01% 1098
2018
Q2
$948K Hold
13,217
0.01% 1043
2018
Q1
$395K Hold
13,217
﹤0.01% 1514
2017
Q4
$439K Buy
+13,217
New +$439K 0.01% 1471